text: <unk>  is an adrenergic alpha-1 antagonist with 5- alpha reductase inhibitor that is FDA approved for the treatment of benign prostatic hyperplasia.   Common adverse reactions include ejaculation disorders, impotence, decreased libido, dizziness, and breast disorders.
option_0: Dutasteride and Tamsulosin hydrochloride
option_1: Finasteride
option_2: Drospirenone and Ethinyl estradiol
option_3: Drospirenone and estradiol
option_4: Spironolactone and hydrochlorothiazide
option_5: Sacubitril and Valsartan
option_6: Tadalafil
option_7: Norgestimate and Ethinyl estradiol